File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles

TitleControllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles
Authors
Issue Date2013
Citation
Journal of the American Chemical Society, 2013, v. 135, n. 15, p. 5709-5716 How to Cite?
AbstractDrug release simultaneously with carrier decomposition has been demonstrated in SiO2-drug composite nanoparticles. By creating a radial drug concentration gradient in the nanoparticle, controllable release of the drug is primarily driven by diffusion. Escape of the drug molecules then triggers the SiO2 carrier decomposition, which starts from the center of the nanoparticle and eventually leads to its complete fragmentation. The small size of the final carrier fragments enables their easy excretion via renal systems. Together with the known biocompatibility of SiO2, the feature of controllable drug release and simultaneous carrier decomposition achieved in the SiO2-drug nanoparticles make it ideal for a wide range of diagnostic and therapeutic applications with great promise for potential clinical translation. © 2013 American Chemical Society.
Persistent Identifierhttp://hdl.handle.net/10722/265650
ISSN
2023 Impact Factor: 14.4
2023 SCImago Journal Rankings: 5.489
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhang, Silu-
dc.contributor.authorChu, Zhiqin-
dc.contributor.authorYin, Chun-
dc.contributor.authorZhang, Chunyuan-
dc.contributor.authorLin, Ge-
dc.contributor.authorLi, Quan-
dc.date.accessioned2018-12-03T01:21:17Z-
dc.date.available2018-12-03T01:21:17Z-
dc.date.issued2013-
dc.identifier.citationJournal of the American Chemical Society, 2013, v. 135, n. 15, p. 5709-5716-
dc.identifier.issn0002-7863-
dc.identifier.urihttp://hdl.handle.net/10722/265650-
dc.description.abstractDrug release simultaneously with carrier decomposition has been demonstrated in SiO2-drug composite nanoparticles. By creating a radial drug concentration gradient in the nanoparticle, controllable release of the drug is primarily driven by diffusion. Escape of the drug molecules then triggers the SiO2 carrier decomposition, which starts from the center of the nanoparticle and eventually leads to its complete fragmentation. The small size of the final carrier fragments enables their easy excretion via renal systems. Together with the known biocompatibility of SiO2, the feature of controllable drug release and simultaneous carrier decomposition achieved in the SiO2-drug nanoparticles make it ideal for a wide range of diagnostic and therapeutic applications with great promise for potential clinical translation. © 2013 American Chemical Society.-
dc.languageeng-
dc.relation.ispartofJournal of the American Chemical Society-
dc.titleControllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1021/ja3123015-
dc.identifier.pmid23496255-
dc.identifier.scopuseid_2-s2.0-84876475814-
dc.identifier.volume135-
dc.identifier.issue15-
dc.identifier.spage5709-
dc.identifier.epage5716-
dc.identifier.eissn1520-5126-
dc.identifier.isiWOS:000317872800035-
dc.identifier.issnl0002-7863-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats